Checkpoint therapeutics, inc. (CKPT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Dec'14
Revenue - related party

972

25

280

1,051

352

3,031

5

127

343

332

349

351

693

498

546

1,249

277

25

0

Operating expenses:
Research and development

2,635

6,730

3,894

4,120

4,581

13,421

7,848

5,453

6,932

4,916

4,955

5,506

3,704

7,743

4,713

5,446

2,365

3,485

0

General and administrative

1,678

2,152

1,620

1,758

1,703

1,502

1,544

1,352

2,194

1,355

1,344

1,317

1,403

1,090

972

1,221

1,184

219

0

Total operating expenses

4,313

8,882

5,514

5,878

6,284

14,923

9,392

6,805

9,126

6,271

6,299

6,823

5,107

8,833

5,685

6,667

3,549

3,704

0

Loss from operations

-3,341

-8,857

-5,234

-4,827

-5,932

-11,892

-9,387

-6,678

-8,783

-5,939

-5,950

-6,472

-4,414

-8,335

-5,139

-5,418

-3,272

-3,679

0

Other income
Interest income

60

31

28

35

42

48

43

39

18

21

22

24

31

12

11

13

11

0

0

Other income

-

-

-

-

-

273

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense and debt amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

344

70

0

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income

60

31

28

35

42

273

43

39

18

21

22

24

31

12

11

13

-333

-70

0

Net Loss

-3,281

-8,826

-5,206

-4,792

-5,890

-11,619

-9,344

-6,639

-8,765

-5,918

-5,928

-6,448

-4,383

-8,323

-5,128

-5,405

-3,605

-3,749

0

Loss per Share:
Basic and diluted net loss per common share outstanding

-0.06

-0.22

-0.15

-0.15

-0.18

-0.37

-0.32

-0.23

-0.35

-0.26

-0.26

-0.28

-0.20

-0.38

-0.24

-0.25

-0.17

-0.44

0.00

Basic and diluted weighted average number of common shares outstanding

50,875

41,705

34,561

32,704

32,243

31,169

29,249

29,044

24,751

22,883

22,801

22,731

22,059

21,875

21,798

21,728

20,775

8,528

8,000